Life Sciences Leaders Advance Unified Engagement at Veeva Commercial Summit
Get Alerts VEEV Hot Sheet
Join SI Premium – FREE
AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly and Company, and more share strategies for more connected customer experiences across sales, marketing, and medical
Veeva CEO
Keynote presenters will include experiences from:
- AstraZeneca standardizing analytics across its brands to boost marketing reach and performance.
- Bayer driving customer-centric, coordinated engagement with Vault CRM.
- Boehringer Ingelheim connecting scientific insights across medical to drive effective, personalized key opinion leader conversations.
- Lilly integrating its content ecosystem by streamlining workflows, standardizing taxonomy, and aligning global teams to deliver high-impact experiences at scale.
- Johnson & Johnson and Madrigal each building a modern data foundation with connected insights for greater efficiency and field impact.
ANI Pharmaceuticals, Gamida Cell, NewAmsterdam Pharma, Orchard Therapeutics, Sobi, and others will also share go-to-market best practices for emerging biotechs at launch and beyond.
"By connecting sales, marketing, and medical, field teams can seamlessly work together to drive more effective, customer-centric experiences," said
Veeva Commercial Summit is one of the largest industry events in
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended
Contact:
Matilde Macieira-Kaufmann
Veeva Systems
925-226-8821
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/life-sciences-leaders-advance-unified-engagement-at-veeva-commercial-summit-302446874.html
SOURCE Veeva Systems
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bullish stock climbs on Stacks token listing expansion
- Alight names Bruce Wolfe as SVP, Wealth Solution Leader
- XTEND confirms $60M cash received as JFB merger nears close
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share